TrovaGene, Inc. (TROV) EPS Estimated At $-0.13; Symmetry Peak Management Has Cut Workday (Call) (WDAY) Position By $1.43 Million

March 9, 2018 - By Peter Erickson

Analysts expect TrovaGene, Inc. (NASDAQ:TROV) to report $-0.13 EPS on March, 21.They anticipate $0.18 EPS change or 58.06% from last quarter’s $-0.31 EPS. After having $-0.12 EPS previously, TrovaGene, Inc.’s analysts see 8.33% EPS growth. The stock decreased 6.79% or $0.026 during the last trading session, reaching $0.357. About 1.57 million shares traded. TrovaGene, Inc. (NASDAQ:TROV) has declined 83.95% since March 9, 2017 and is downtrending. It has underperformed by 100.65% the S&P500.

Symmetry Peak Management Llc decreased Workday Inc (Call) (WDAY) stake by 41.46% reported in 2017Q3 SEC filing. Symmetry Peak Management Llc sold 13,600 shares as Workday Inc (Call) (WDAY)’s stock rose 10.62%. The Symmetry Peak Management Llc holds 19,200 shares with $2.02 million value, down from 32,800 last quarter. Workday Inc (Call) now has $28.76B valuation. The stock decreased 0.47% or $0.64 during the last trading session, reaching $136.94. About 1.32M shares traded. Workday, Inc. (NYSE:WDAY) has risen 32.94% since March 9, 2017 and is uptrending. It has outperformed by 16.24% the S&P500.

Among 49 analysts covering Workday (NYSE:WDAY), 19 have Buy rating, 4 Sell and 26 Hold. Therefore 39% are positive. Workday had 200 analyst reports since August 5, 2015 according to SRatingsIntel. As per Friday, November 3, the company rating was maintained by Jefferies. The firm has “Equal-Weight” rating by Barclays Capital given on Thursday, August 25. The firm has “Buy” rating by Canaccord Genuity given on Monday, October 3. The stock of Workday, Inc. (NASDAQ:WDAY) earned “Buy” rating by MUFG Securities Americas Inc on Wednesday, October 11. The stock of Workday, Inc. (NASDAQ:WDAY) earned “Sell” rating by UBS on Thursday, November 9. The stock of Workday, Inc. (NASDAQ:WDAY) earned “Hold” rating by Deutsche Bank on Friday, September 16. The rating was maintained by Guggenheim with “Hold” on Wednesday, February 28. On Wednesday, July 20 the stock rating was downgraded by Citigroup to “Neutral”. On Thursday, August 17 the stock rating was maintained by BMO Capital Markets with “Market Perform”. The stock of Workday, Inc. (NASDAQ:WDAY) has “Buy” rating given on Thursday, August 31 by Canaccord Genuity.

Investors sentiment decreased to 1.62 in 2017 Q3. Its down 0.16, from 1.78 in 2017Q2. It dropped, as 24 investors sold WDAY shares while 78 reduced holdings. 58 funds opened positions while 124 raised stakes. 139.45 million shares or 0.57% more from 138.65 million shares in 2017Q2 were reported. State Common Retirement Fund holds 435,744 shares. 2,300 are held by Qs Ltd Limited Liability Company. Northwestern Mutual Wealth Mgmt invested 0% in Workday, Inc. (NASDAQ:WDAY). 1832 Asset Management Limited Partnership invested in 0.17% or 484,000 shares. Fisher Asset Mgmt Limited Liability accumulated 7,293 shares or 0% of the stock. Hightower Advisors Limited Com holds 0.02% of its portfolio in Workday, Inc. (NASDAQ:WDAY) for 20,805 shares. Aperio Grp Ltd Liability Corp holds 0.01% or 19,632 shares in its portfolio. Cambridge Invest Rech Advsrs owns 7,797 shares. 75,372 are owned by Raymond James And Associates. 1.84M were reported by Goldman Sachs Group Inc. Kbc Group Nv owns 22,520 shares. Jane Street Gp Lc accumulated 33,832 shares or 0.01% of the stock. Lpl Fin Ltd Company holds 0% or 9,250 shares. Panagora Asset Inc owns 0.01% invested in Workday, Inc. (NASDAQ:WDAY) for 20,317 shares. San Francisco Sentry Invest Grp (Ca) reported 23 shares.

Symmetry Peak Management Llc increased Broadcom Ltd (Put) stake by 12,500 shares to 20,000 valued at $4.85 million in 2017Q3. It also upped Varonis Sys Inc (NASDAQ:VRNS) stake by 13,991 shares and now owns 21,491 shares. Tesla Inc (Call) (NASDAQ:TSLA) was raised too.

Since September 12, 2017, it had 0 buys, and 37 selling transactions for $199.86 million activity. $1.37 million worth of Workday, Inc. (NASDAQ:WDAY) was sold by Bozzini James. $2.01M worth of Workday, Inc. (NASDAQ:WDAY) shares were sold by PEEK MARK S. Shares for $565,451 were sold by Sisco Robynne on Monday, October 16. Stankey Michael A. had sold 7,569 shares worth $840,109 on Tuesday, January 16. 4,024 Workday, Inc. (NASDAQ:WDAY) shares with value of $432,591 were sold by DUFFIELD DAVID A. 5,160 Workday, Inc. (NASDAQ:WDAY) shares with value of $553,709 were sold by WILMINGTON PHILIP W. Another trade for 6,409 shares valued at $663,166 was made by Shaughnessy James P on Friday, December 15.

Trovagene, Inc., a clinical-stage, precision medicine oncology therapeutics company, develops oncology therapeutics for cancer care by leveraging its proprietary Precision Cancer Monitoring technology in tumor genomics. The company has market cap of $19.74 million. The Company’s lead drug candidate, PCM-075, is a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor. It currently has negative earnings. The PCM-075 is an orally bioavailable, which has explored in preclinical antitumor activity as a single agent and in synergy combinations with approximately 10 different chemotherapeutics and targeted therapies, such as Zytiga (abiraterone acetate), Beleodaq (belinostat), Quizartinib, a development stage FLT3 inhibitor, and Velcade (bortezomib) in acute myeloid leukemia (AML), metastatic castration-resistant prostate cancer, and other liquid and solid tumor cancers.

Investors sentiment decreased to 0.53 in Q3 2017. Its down 0.32, from 0.85 in 2017Q2. It fall, as 10 investors sold TrovaGene, Inc. shares while 10 reduced holdings. 9 funds opened positions while 8 raised stakes. 5.05 million shares or 53.72% more from 3.29 million shares in 2017Q2 were reported. Deutsche Retail Bank Ag holds 0% or 371 shares. Citadel Advsr holds 10,660 shares. California Public Employees Retirement System owns 77,200 shares or 0% of their US portfolio. Cwm Ltd Liability reported 1,000 shares. Northern Trust Corporation holds 0% or 54,410 shares in its portfolio. Savings Bank Of America De holds 6,825 shares or 0% of its portfolio. Tci Wealth holds 700 shares. Sabby Ltd Liability Corporation has invested 0.08% in TrovaGene, Inc. (NASDAQ:TROV). Moreover, Morgan Stanley has 0% invested in TrovaGene, Inc. (NASDAQ:TROV). Meeder Asset Mgmt invested in 2,582 shares or 0% of the stock. Bnp Paribas Arbitrage Sa has 21 shares. Northwestern Mutual Wealth Mgmt invested in 0% or 3,400 shares. Vanguard has invested 0% in TrovaGene, Inc. (NASDAQ:TROV). 22,300 are owned by Cambridge Invest Advsrs Incorporated. Princeton Cap Inc holds 0.01% or 17,070 shares in its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:

Recent Posts